Zhang Cheng

Beijing, 100191, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

The Bidirectional Relationship between Weight Gain and Cognitive Function in First-Episode Schizophrenia: A Longitudinal Study in China.

The Bidirectional Relationship between Weight Gain and Cognitive Function in First-Episode Schizophrenia: A Longitudinal Study in China.

Journal: Brain sciences

Published: February 25, 2024

Trajectories of social function in patients with first-episode schizophrenia: Analysis of data from a 10-year follow-up study.

Trajectories of social function in patients with first-episode schizophrenia: Analysis of data from a 10-year follow-up study.

Journal: Asian journal of psychiatry

Published: August 04, 2023

Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China.

Weight changes following treatment with aripiprazole, risperidone and olanzapine: A 12-month study of first-episode schizophrenia patients in China.

Journal: Asian journal of psychiatry

Published: February 01, 2023

Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia.

Optimal cutoff scores of the Chinese version of 15-item negative symptom assessment that indicate prominent negative symptoms of schizophrenia.

Journal: Frontiers in psychiatry

Published: January 30, 2023

Neurocognitive trajectories and their clinical implications in first-episode schizophrenia after one year of antipsychotic treatment.

Neurocognitive trajectories and their clinical implications in first-episode schizophrenia after one year of antipsychotic treatment.

Journal: Schizophrenia research

Published: November 24, 2020

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia.

Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia.

Journal: Neuropsychiatric disease and treatment

Published: September 11, 2020

Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia.

Neurocognitive effects of atypical antipsychotics in patients with first-episode schizophrenia.

Journal: Nordic journal of psychiatry

Published: June 05, 2020

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?

Which Subgroup of First-Episode Schizophrenia Patients Can Remit During the First Year of Antipsychotic Treatment?

Journal: Frontiers in psychiatry

Published: February 20, 2020

Influence of More Than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic Schizophrenia.

Influence of More Than 5 Years of Continuous Exposure to Antipsychotics on Cerebral Functional Connectivity of Chronic Schizophrenia.

Journal: Canadian journal of psychiatry. Revue canadienne de psychiatrie

Published: February 07, 2020

What is the optimal neuropsychological test battery for schizophrenia in China?

What is the optimal neuropsychological test battery for schizophrenia in China?

Journal: Schizophrenia research

Published: July 16, 2018

Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial.

Rates and predictors of one-year antipsychotic treatment discontinuation in first-episode schizophrenia: Results from an open-label, randomized, "real world" clinical trial.

Journal: Psychiatry research

Published: May 02, 2018

The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China.

The MATRICS Consensus Cognitive Battery (MCCB): Co-norming and standardization in China.

Journal: Schizophrenia research

Published: June 13, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026